Form D · Other Technology
Hazel Health, Inc.
Irving, TX · CIK 0001814186
Offering snapshot reported Jun 11, 2025 · SEC filing
- Reported sold
- $34.5M Offering amount: $34.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2025 | Initial | $34,499,989 | No comparison | 10 | SEC filing |
| Jun 11, 2025 | Initial | $51,499,964 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548609
Source: Form D, filed Jun 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeannie Chen | Director |
| Mary Ann Christopher | Director |
| Jeremy Delinsky | Director |
| Abigail Andrews Flinn | Director |
| Joshua Golomb | Director |
| Michael Krupka | Director |
| Tory Patterson | Director |
| Iyah Romm | Director, Executive |
| Jeffrey Sinko | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8300 Esters Blvd., Suite 900
Irving, TX, 75063
Irving, TX, 75063